InBody Announces Presence at Spring Obesity Medicine 2018

April 05, 2018

The medical device manufacturer will offer solutions to help obesity medicine attendees make informed decisions regarding patients’ treatment

CERRITOS, CA (April 5, 2018) – InBody, a medical device manufacturer, will be at the spring Obesity Medicine 2018 to showcase the InBody 570. The event is organized by the Obesity Medicine Association (OMA) and will be held at the Manchester Grand Hyatt in San Diego, April 4 to April 5. InBody will offer complimentary body composition analyses and consultations at the conference.

“InBody devices provide a detailed, research-backed approach to improving patient care,” said David Hamamura, InBody district manager. “Data generated by the devices help professionals create and prove the effectiveness of a customized treatment plan.”

In 45 seconds, the InBody 570 will provide attendees with:

  • Body Composition History: See that a patient is losing fat mass and retaining muscle mass over time.
  • Segmental Lean Analysis: Identify how many pounds of lean mass are in the arms, trunk, and legs separately to identify imbalances that can compromise mobility.
  • Visceral Fat Analysis: Learn how much fat is surrounding major organs, increasing the risk of diseases.
  • Basal Metabolic Rate: Find out how many calories are burned at rest to guide nutritional recommendations.

InBody devices are space-efficient, medically validated and don’t rely on preloaded data pertaining to gender, age or ethnicity. Information regarding professional demos and other InBody products will also be available at the booth.